Skip to main content

Table 2 Main unit costs and prices

From: Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

Items

Unit costs and prices

Sources of information

Hospitalization (per day)

760,14€

Hospital Managers

Biopsy

51,45 €

[19, 20]

Consultation (external)

68,73€

[19, 20]

Radiotherapy (per session)

94,21€

[19, 20]

Chemo-therapy(per milligram of drugs)

Caelix

17,74€

Hospital pharmacists

 

Carboplatin

0,21€

Hospital pharmacists

 

Cisplatin

0,32€

Hospital pharmacists

 

Deticene

0,03€

Hospital pharmacists

 

Doxorubicin

0,71€

Hospital pharmacists

 

Etopophos etoposide

0,16€

Hospital pharmacists

 

Gemcitabine

0,17€

Hospital pharmacists

 

Holoxan

0,07€

Hospital pharmacists

 

Ifosfamide

0,10€

Hospital pharmacists

 

Imatinib

0,24€

Hospital pharmacists

 

Melphalan

0,01€

Hospital pharmacists

 

Navelbine

1,91€

Hospital pharmacists

 

Oxaliplatin

3,92€

Hospital pharmacists

 

Paclitaxel

2,25€

Hospital pharmacists

 

Vincristine

7,16€

Hospital pharmacists

Transfusion (per pack)

Ps

121,33€

[19, 21]

 

Red blood cell

104,57€

[19, 21]

Imaging(per exam.)

Chest radiograph

22,49€

[19, 20]

 

Colonoscopy

121,58€

[19, 20]

 

Computed Tomography

83,20€

[19, 20]

 

Ultrasound

50,48€

[19, 20]

 

Magnetic Resonance Imaging

139,50€

[19, 20]

  1. Relapse-free survival three years after diagnosis was taken as the indicator of effectiveness. Mean relapse-free survival was calculated for CPG-compliant and non compliant groups.